This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Amicus Therapeutics Inc (FOLD)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 24.07M 43.64M 33.97M 25.67M
Receivables 0.00 759.00K 3.22M 5.04M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 154.58M 88.28M 104.62M 66.65M
Property, Plant & Equipment, Gross 14.33M 14.09M 13.53M 11.94M
Accumulated Depreciation & Depletion 11.52M 9.97M 8.50M 9.51M
Property, Plant & Equipment, Net 2.81M 4.12M 5.03M 2.44M
Intangibles 23.00M 0.00 0.00 0.00
Other Non-Current Assets 17.97M 23.55M 442.00K 709.00K
Total Non-Current Assets 55.39M 39.28M 5.47M 3.15M
Liabilities & Shareholder Equity
Total Assets 209.97M 127.56M 110.09M 69.80M
Accounts Payable 6.22M 2.15M 8.84M 2.58M
Short Term Debt 3.84M 299.00K 398.00K 1.04M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 20.18M 10.46M 9.24M 19.26M
Long Term Debt 10.51M 14.17M 299.00K 0.00
Deferred Income Taxes 9.19M 9.19M 30.42M 0.00
Other Non-Current Liabilities 47.91M 47.99M 908.00K 20.95M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 67.60M 71.35M 31.62M 20.95M
Total Liabilities 87.79M 81.81M 40.87M 40.20M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 122.18M 45.75M 69.22M 29.59M
Common Par 1.02M 679.00K 556.00K 407.00K
Additional Paid In Capital 568.74M 423.59M 387.54M 299.28M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -447.45M -378.52M -318.89M -270.10M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -132.00K 1.00K 14.00K 4.00K
Total Capitalization 132.69M 59.92M 69.52M 29.59M
Total Equity 122.18M 45.75M 69.22M 29.59M
Total Liabilities & Stock Equity 209.97M 127.56M 110.09M 69.80M
Total Common Shares Outstanding 95.56M 61.98M 49.63M 34.65M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 74.44M 51.29M 45.57M 34.57M
Diluted Weighted Shares Outstanding 74.44M 51.29M 45.57M 34.57M
Number of Employees 97 92 112 96
Number of Part-Time Employees 0 0 0 0

FOLD Amicus Therapeutics Inc

Chart of FOLD

Analysts Ratings for FOLD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 4
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

FOLD Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs